Allurion Technologies
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$750k | Debt | ||
$1.6m | Early VC | ||
$1.3m | Early VC | ||
$1.6m | Early VC | ||
$6.0m | Early VC | ||
$19.0m | Late VC | ||
$27.0m | Series C | ||
$34.0m | Early VC | ||
$25.0m Valuation: $170m | Early VC | ||
* | $863m | SPAC IPO | |
* | N/A | Post IPO Debt | |
* | $100m | Post IPO Equity | |
* | $48.0m | Post IPO Equity | |
* | $20.0m | Post IPO Equity | |
Total Funding | CAD157m |
Related Content
Recent News about Allurion Technologies
EditAllurion Technologies Inc. is a pioneering company in the healthcare sector, specifically targeting obesity management. The company has developed the Allurion Balloon, the world's first weight loss balloon that does not typically require surgery, endoscopy (a procedure where a tube with a camera is inserted into the body), or anesthesia for placement or removal. This innovative product is designed to help patients lose weight safely and effectively.
The Allurion Program is comprehensive, combining the Allurion Balloon with a suite of digital tools and devices. These include the Allurion Virtual Care Suite, which features the Allurion Mobile App for consumers, Allurion Insights for clinicians, and the Allurion Connected Scale and Health Tracker devices. This integrated approach allows both patients and healthcare providers to customize, monitor, and manage weight loss therapy effectively.
Allurion primarily serves individuals struggling with obesity who are looking for non-surgical weight loss solutions. The company also collaborates with healthcare providers who offer the Allurion Program to their patients. The market for Allurion's products and services is global, although the Allurion Balloon is not currently approved in the United States.
The business model of Allurion is based on selling its weight loss balloon and the accompanying digital tools and devices. The company generates revenue through direct sales to healthcare providers and possibly through subscription services for its digital tools. By offering a full package of support, Allurion ensures a continuous revenue stream from both initial product sales and ongoing digital service subscriptions.
In summary, Allurion is revolutionizing the weight loss industry with its non-invasive, easy-to-use gastric balloon and comprehensive digital support system, aiming to make significant strides in the fight against obesity.
Keywords: obesity management, weight loss balloon, non-surgical, digital health, healthcare providers, global market, Allurion Program, Virtual Care Suite, patient support, innovative healthcare.